The U.S. home infusion therapy market is poised for growth due to an aging population and rising chronic diseases such as ...

“Our data shows that as many as 20% of breast cancer survivors on aromatase inhibitors will stop taking their medication ...

Histopathological image of multiple myoloma. Smear preparation of bone marrow aspirate stained with May-Grünwald-Giemsa procedure. It doest not represent a histopathologic image but essentially helps ...

Lupus is a debilitating autoimmune disease that affects around 1.5 million Americans. Now, new research shows a therapy ...

MONTROSE, Colo. (KJCT) - Montrose Regional Health held a grand opening for the new Francie Smiles Infusion Center, expanding ...

The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to ...

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...

The cancer center is the first department to open in the old St. Joseph's facility. The Chippewa Valley Health Cooperative ...

About 18 years ago, a 4-year-old girl with a rare nerve cell cancer received an infusion of immune cells that were genetically engineered to fight the disease. Since then, she has remained cancer-free ...

The FDA approved pertuzumab-dpzb (Poherdy) as the first biosimilar for its reference product Perjeta, a monoclonal antibody commonly used in standard regimens for HER2-positive breast cancer. FDA ...